Copyright
©The Author(s) 2022.
World J Diabetes. Jul 15, 2022; 13(7): 498-520
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.498
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.498
Table 1 Major components of the glomerular basement membrane and the mesangial matrix in normal human glomeruli
Glomerular basement membrane | Mesangial matrix | |
Heparan sulfate proteoglycan | Abundant | Abundant |
Laminin | Major component | Minor component |
Fibronectin | Minor component | Major component |
Type I collagen | Absent in most studies | Absent in most studies |
Type III collagen | Absent in most studies | Absent in most studies |
Type IV collagen | Major component | Present (inconsistent amounts) |
Type V collagen | Present | Present |
Type VI collagen | Present | Present |
Type XVII collagen | Present | Unknown |
Type XVIII collagen | Present | Present |
Tubulointerstitial nephritis antigen-like-1 | Low abundance | High abundance |
Nidogen / Entactin | Present | Low abundance |
Fibulin-1 | Present | Present |
Fibrillin-1 | Present | Present |
Nephronectin | Present | Present |
Vitronectin | Absent | Present |
Microfibril-associated proteins | Absent | Present |
Table 2 Staining characteristics of the mesangial deposits in diabetic kidney diseases, fibronectin-1 nephropathy, and type III collagen glomerulopathy
Periodic acid Schiff | Methenamine silver | Congo red | Specific analysis | |
Diabetic kidney disease | Positive | Positive | Negative | Unknown material |
Fibronectin-1 nephropathy | Positive | Negative | Negative | Fibronectin-1 |
Type III collagen nephropathy | Negative | Negative | Negative | Type III collagen |
Table 3 Type IV collagen-related kidney disease
Gene/location | Protein | Mutation | Risk of progression to end-stage kidney disease | |
X-linked Alport syndrome | COL4A5/X chromosome | α5 chain of type IV collagen | Hemizygous (males) or heterozygous (females) mutations | Hemizygous: 100%; Heterozygous: 25% |
Autosomal recessive Alport syndrome | COL4A4 or COL4A3/2q36-37 | α4 and α3 chains of type IV collagen | Biallelic (homozygous or compound heterozygous) mutations | 100% |
Autosomal dominant Alport syndrome | COL4A4 or/COL4A32q36-37 | α4 and α3 chains of type IV collagen | Heterozygous mutations in the α4 or α3 chains | 20% in patients with risk factors for progression |
Digenic Alport syndrome | Two of the COL4A3-5 genes | Two of the α3-5 chains |
Table 4 Different composition of glomerular extracellular matrix (glomerular basement membrane and mesangial matrix) in normal subjects and patients with diabetes
Normal glomeruli | Diabetic kidney disease | |
Heparan sulfate proteoglycans | GBM and mesangial matrix | Decreased amount |
Laminin | Predominantly in the GBM | Inconsistent |
Fibronectin-1 | Mainly in the mesangial matrix | It varies according to DKD stage |
Type I collagen | Inconsistent | No detectable |
Type III collagen | Absent | Abundant |
Type IV collagen | Abundant in the GBM | Reduced GBM amount |
Type V collagen | Similar to type IV collagen | Increased mesangial amount |
Type VI collagen | GBM and mesangial matrix | Increased mesangial amount |
- Citation: Adeva-Andany MM, Carneiro-Freire N. Biochemical composition of the glomerular extracellular matrix in patients with diabetic kidney disease. World J Diabetes 2022; 13(7): 498-520
- URL: https://www.wjgnet.com/1948-9358/full/v13/i7/498.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i7.498